Hematology Transfusion and Cell Therapy

Scope & Guideline

Pioneering insights in hematology and transfusion care.

Introduction

Welcome to the Hematology Transfusion and Cell Therapy information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Hematology Transfusion and Cell Therapy, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2531-1379
PublisherELSEVIER
Support Open AccessYes
CountryBrazil
TypeJournal
Convergefrom 2018 to 2024
AbbreviationHEMATOL TRANSF CELL / Hematol. Transf. Cell Ther.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Hematology Transfusion and Cell Therapy' focuses on advancing the understanding and treatment of hematological disorders and transfusion medicine. It aims to publish high-quality research that contributes to the clinical practice and scientific knowledge in these fields.
  1. Hematological Disorders:
    The journal covers a wide range of hematological conditions, including leukemias, lymphomas, myelomas, and other blood disorders, emphasizing both clinical and laboratory research.
  2. Transfusion Medicine:
    Research related to blood transfusion practices, safety, and efficacy, including studies on blood components, transfusion reactions, and management protocols.
  3. Cell Therapy and Stem Cell Transplantation:
    Focus on advancements in cell therapies, including hematopoietic stem cell transplantation techniques, outcomes, and challenges, particularly in resource-limited settings.
  4. Infectious Complications in Hematology:
    Exploration of infectious risks associated with hematological diseases and treatments, particularly in the context of COVID-19 and other emerging infections.
  5. Genetic and Molecular Studies:
    Research investigating genetic factors influencing hematological diseases, including molecular diagnostics, biomarkers for disease prognosis, and treatment responses.
  6. Patient Management and Quality of Life:
    Studies addressing patient care strategies, including management of symptoms, side effects of treatments, and overall patient quality of life in hematological settings.
Recent publications indicate emerging themes and trends that reflect the evolving landscape of hematology, transfusion medicine, and cell therapy. These trends highlight the journal's responsiveness to current challenges and advancements in the field.
  1. Impact of COVID-19 on Hematology:
    A significant increase in research addressing the effects of COVID-19 on patients with hematological conditions, including complications, treatment adaptations, and vaccination responses.
  2. Personalized Medicine and Targeted Therapies:
    Growing emphasis on studies exploring personalized treatment approaches in hematology, particularly the use of genetic markers for tailoring therapies.
  3. Patient Blood Management Strategies:
    Emerging focus on optimizing blood use in clinical settings, including protocols for minimizing transfusions and improving patient outcomes.
  4. Innovations in Cell Therapy:
    Increased interest in novel cell therapies, including CAR-T cell therapy and other advanced therapeutic modalities targeting hematological malignancies.
  5. Health Equity and Access to Care:
    Research highlighting disparities in healthcare access and outcomes for hematology patients, particularly in low- and middle-income countries.
  6. Quality of Life Assessments:
    Growing trend towards evaluating the quality of life and psychosocial impacts of hematological diseases and treatments, reflecting a holistic approach to patient care.

Declining or Waning

While the journal continues to explore a wide range of topics, some areas have shown a decline in publication frequency or emphasis over recent years. This may reflect shifts in research focus or advancements in other areas.
  1. Traditional Hematology Techniques:
    There is a noticeable decrease in studies focusing solely on traditional hematological laboratory techniques, as advancements in molecular and genetic diagnostics gain prominence.
  2. Basic Science Research:
    Research that does not directly translate to clinical application is becoming less frequent, as the journal emphasizes studies with immediate clinical relevance.
  3. Historical Perspectives on Hematology:
    Papers focusing on historical analyses or reviews of past practices in hematology are becoming less common, reflecting a shift towards contemporary issues and innovations.

Similar Journals

TRANSFUSION AND APHERESIS SCIENCE

Advancing the Frontiers of Hematology and Transfusion Medicine
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1473-0502Frequency: 6 issues/year

TRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.

TRANSFUSION

Fostering Collaboration in Hematology Excellence
Publisher: WILEYISSN: 0041-1132Frequency: 12 issues/year

TRANSFUSION is a prestigious peer-reviewed journal published by WILEY, dedicated to advancing the field of hematology and transfusion medicine. With an ISSN of 0041-1132 and an E-ISSN of 1537-2995, this journal serves as a vital resource for researchers and professionals alike, delivering high-quality studies and reviews that impact clinical practice and blood management strategies. The journal enjoys a strong reputation, evidenced by its impressive Q1 ranking in hematology and Q2 in both immunology and allergy as of 2023. Covering foundational aspects from 1958 to 2024, TRANSFUSION not only provides valuable insights but also fosters collaboration and innovation in understanding the complexities of blood donation, transfusion practices, and immunological responses. With its significant contributions to the scientific community, this journal is essential for those seeking to stay at the forefront of research and advancements in transfusion science.

Anemia

Unlocking the mysteries of blood disorders, one study at a time.
Publisher: HINDAWI LTDISSN: 2090-1267Frequency: 1 issue/year

Anemia is a distinguished open-access journal published by HINDAWI LTD, focusing on the intricate and vital field of hematology and related disciplines. Since its inception in 2010, this journal has been dedicated to advancing our understanding of blood disorders, with a particular emphasis on anemia, through the dissemination of high-quality research that is freely accessible to a global audience. The journal's evolving scope from its founding through 2024 embodies its commitment to include the latest breakthroughs and methodologies in cell biology and hematological research. With its presence in prestigious databases and a tiered ranking that places it in the Q3 category in Hematology and Q4 in Cell Biology as of 2023, Anemia serves as an invaluable resource for researchers, clinicians, and students alike. The journal is indexed with a respectable position in Scopus, ranking 52 out of 137 in Hematology, highlighting its growing influence in the medical and scientific communities. With continued emphasis on open access, Anemia not only fosters collaborative research but also ensures that crucial findings reach those who need them most, enhancing educational outcomes and clinical practices worldwide.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Unveiling Cutting-Edge Research in Clinical Pathology
Publisher: OXFORD UNIV PRESS INCISSN: 0002-9173Frequency: 12 issues/year

The American Journal of Clinical Pathology, published by Oxford University Press Inc, stands as a vital resource in the fields of pathology and clinical medicine. With a rich history dating back to 1945 and an impressive impact factor reflected in its Q1 ranking in Pathology and Forensic Medicine, this journal serves as a cornerstone for researchers and professionals seeking to advance their knowledge and practice. Covering a breadth of topics within the discipline, it is recognized in 2023 as ranked #24 out of 208 in its category, highlighting its esteemed reputation within the scientific community. Although the journal does not currently offer open access, its rigorous peer-reviewed articles and cutting-edge research make it an essential addition to any academic or clinical library. The ISSN for print version is 0002-9173, with an E-ISSN of 1943-7722 available for digital access. Researchers, students, and practitioners alike will benefit from its comprehensive scope and commitment to disseminating high-quality scientific inquiry.

VOX SANGUINIS

A Voice for Groundbreaking Hematological Discoveries
Publisher: WILEYISSN: 0042-9007Frequency: 12 issues/year

VOX SANGUINIS is a distinguished peer-reviewed journal in the fields of Hematology and Medicine, published by Wiley, a leading academic publisher based in the United Kingdom. With a rich history dating back to its inception in 1952, this journal has consistently provided a platform for innovative research and insightful reviews, advancing the understanding of blood-related disorders and therapies. As evidenced by its robust performance—ranking #57 out of 137 in Scopus for Medicine in Hematology and holding a Q2 classification in both Hematology and miscellaneous Medicine categories—VOX SANGUINIS is recognized for its significant contributions to the scientific community. This journal serves as a vital resource for researchers, professionals, and students alike, fostering knowledge exchange and collaboration within the field. With its ongoing commitment to quality and integrity, VOX SANGUINIS continues to shape the future of hematological research well into 2024 and beyond.

INTERNATIONAL JOURNAL OF HEMATOLOGY

Elevating Hematology Research to New Heights
Publisher: SPRINGER JAPAN KKISSN: 0925-5710Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.

Hematology-American Society of Hematology Education Program

Unlocking Insights for Hematology Professionals
Publisher: AMER SOC HEMATOLOGYISSN: 1520-4391Frequency: 1 issue/year

Hematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.

TRANSFUSION CLINIQUE ET BIOLOGIQUE

Innovating transfusion medicine with every publication.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 1246-7820Frequency: 4 issues/year

TRANSFUSION CLINIQUE ET BIOLOGIQUE, an esteemed journal published by Elsevier France - Éditions Scientifiques Médicales Elsevier, has been a pivotal resource in the fields of transfusion medicine, biochemistry, and hematology since its inception in 1994. With a strong commitment to advancing scientific knowledge, this journal provides a platform for high-quality research and clinical studies aimed at improving patient care and outcomes in transfusion practices. Although categorized in Q3 and Q4 quartiles across multiple categories in Biochemistry and Medicine for 2023, the journal holds significant potential for growth and impact within the scientific community. While it currently does not offer open access options, its indexing in reputable databases ensures visibility and reach among professionals and researchers. As the field evolves, TRANSFUSION CLINIQUE ET BIOLOGIQUE aims to continue fostering innovation and collaboration, making it a valuable tool for anyone involved in medical, biochemical, and hematological research.

Therapeutic Advances in Hematology

Advancing hematology through innovative research.
Publisher: SAGE PUBLICATIONS LTDISSN: 2040-6207Frequency: 1 issue/year

Therapeutic Advances in Hematology is a prestigious, peer-reviewed journal dedicated to advancing the field of hematology through innovative research and clinical studies. Published by SAGE Publications Ltd, this journal has become a vital resource for hematology professionals and researchers since its inception in 2010. With its impactful Q1 ranking in Hematology and a Scopus rank of 62 out of 137, it firmly establishes itself as a leader in disseminating significant findings and therapeutic approaches. The journal has been committed to open access since 2019, ensuring that its cutting-edge research is readily available to the global scientific community. Covering a broad scope of topics within hematology, Therapeutic Advances in Hematology is an essential platform for those seeking to enhance their understanding and implementation of therapeutic practices in hematological conditions. The journal embraces submissions from both clinical and laboratory perspectives, fostering collaboration and dialogue among researchers, clinicians, and students alike.

TRANSFUSION MEDICINE REVIEWS

Transforming knowledge into clinical excellence.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-7963Frequency: 4 issues/year

TRANSFUSION MEDICINE REVIEWS is a prestigious journal dedicated to the advanced study of transfusion medicine and its related fields, published by W B SAUNDERS CO-ELSEVIER INC. With an outstanding reputation, it boasts an impressive impact factor and consistently ranks in the top quartile (Q1) across multiple categories, including Biochemistry (Medical), Clinical Biochemistry, and Hematology. Researchers will find valuable insights through its extensive coverage of pertinent topics, with a focus on the integration of clinical practices and laboratory science. While the journal does not currently offer open access, its content remains accessible through various institutional subscriptions, ensuring that vital information is available to the global scientific community. With a continuous publication history from 1987 to 2024, TRANSFUSION MEDICINE REVIEWS serves as a vital resource for academics, healthcare professionals, and students who seek to stay abreast of the latest research findings and clinical practices in transfusion medicine.